In this study, considering the unique mutation spectrum of Chinese lung cancer patients compared to the western population, we investigated the frequency and mutation spectrum of ERBB2 TMD mutations in Chinese lung cancer population, which would further our insights for treating ERBB2 TMD mutant patients. This evidence concerns the gene ERBB2 and lung carcinoma.